Size-exclusion chromatography raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-10-07. Anything still debated is marked as such rather than presented as settled.
Collagen is a structural protein found in skin, bone, tendon, and cartilage, where it forms a triple helix of three polypeptide chains. The chains contain repeating Gly-X-Y sequences, with proline and hydroxyproline frequently occupying the X and Y positions. Collagen peptides are fragments produced by breaking these long chains through hydrolysis. These fragments vary in length and amino acid composition depending on the source and processing method, so the term covers a range of products rather than a single defined molecule.
Hydrolysis converts native collagen into shorter peptides and improves water solubility. Enzymatic treatment with proteases such as pepsin or alkaline proteases is common, though acid or thermal hydrolysis can also be used. The resulting molecular weight distribution typically ranges from about 2 to 10 kilodaltons. Gelatin is a related product formed by partial hydrolysis, but it retains the ability to gel in water. Collagen peptides undergo further breakdown and generally do not form gels.
Commercial collagen peptides come from bovine hide, porcine skin, fish scales, and fish skin. Each source yields a distinct amino acid profile, including different levels of hydroxyproline and glycine. Marine sources often have lower hydroxyproline content than mammalian sources. Production involves extraction, hydrolysis, filtration, and drying, usually spray drying. The final powder is typically white to off-white and dissolves readily in water. Exact composition and peptide size depend on the raw material and the hydrolysis conditions.
Stability depends on moisture, temperature, oxygen, and packaging. Dry collagen peptide powders are generally stable when kept cool and dry, but humid conditions can cause clumping and microbial growth. Heat exposure may promote Maillard reactions if reducing sugars are present, altering color and flavor. Solutions are less stable than powders and may support microbial proliferation unless preserved or refrigerated; light exposure can also affect appearance over time. Shelf-life claims vary and should be supported by real-time or accelerated stability data.
Quality control for collagen peptides may include identity, purity, and contaminant testing. Identity can be supported by amino acid profile and hydroxyproline content; purity checks may examine moisture, ash, protein content, and peptide size range. Heavy metals, microbial counts, and residual solvents are relevant for materials intended for ingestion. Some suppliers use peptide fingerprinting or source-specific markers, though these methods are not universally standardized. Documentation such as certificates of analysis helps verify that a batch meets agreed specifications.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for spray-dried hydrolysates |
| Solubility | Water-soluble | Forms clear solutions at moderate concentrations |
| Molecular weight range | 2–10 kDa | Depends on hydrolysis time and enzyme |
| Storage temperature | 15–25 °C | Keep sealed and protect from moisture |
| Common synonyms | Collagen hydrolysate, hydrolyzed collagen | Not identical to gelatin |
Manufacturing collagen peptides begins with collagen-rich raw materials such as bovine hide, porcine skin, fish scales, or poultry cartilage, which undergo washing, size reduction, and pretreatment to remove non-collagen proteins and fats. Extraction may use acid, alkali, or heat. Hydrolysis then breaks the collagen into smaller peptides, often with enzymes such as pepsin, papain, or alcalase. Process conditions of time, temperature, pH, and enzyme dose determine the final molecular weight distribution. After hydrolysis, the solution is filtered, concentrated, and dried into powder.
Quality testing of collagen peptides relies on several analytical methods. Molecular weight distribution is commonly measured by size-exclusion chromatography, sometimes paired with multi-angle light scattering. Amino acid composition is determined by ion-exchange chromatography or reversed-phase high-performance liquid chromatography after acid hydrolysis, while protein content is estimated by Kjeldahl or Dumas nitrogen analysis. Moisture, ash, and heavy metals are checked against specification limits. These tests help ensure consistency and detect adulteration with other proteins.
Regulatory treatment of collagen peptides varies by country and intended use. In the United States, they are typically marketed as dietary supplements or food ingredients, and certain uses may be generally recognized as safe (GRAS) through self-affirmation or notification. In the European Union, collagen peptides from approved animal sources are considered food, not novel foods, if they have a history of consumption. Health claims linking collagen peptides to joint or skin benefits are not approved in the US or EU. Labeling must list the animal source and may state the protein content.
Dry collagen peptide powder is generally stable when kept in a sealed container away from moisture, heat, and direct sunlight. The powder is hygroscopic and can clump if exposed to humid air, so desiccant packets are sometimes included. In solution, collagen peptides are susceptible to microbial growth unless preserved or refrigerated. Prolonged exposure to high temperatures may cause aggregation or color changes. Typical storage recommendations are cool and dry conditions at ambient temperature.
Quality control for collagen peptides includes measurements of moisture content, ash, protein content, and heavy metals. Microbial limits are set to ensure food or cosmetic grade safety, and the degree of hydrolysis serves as a key process indicator. That indicator correlates with molecular weight distribution and solubility characteristics. Regulatory requirements vary by country, and some jurisdictions restrict label claims about health effects. Documentation such as certificates of analysis and safety data sheets typically accompanies commercial shipments of the material.
Analytical testing of collagen peptides focuses on identity, purity, and molecular weight profile. Size-exclusion chromatography separates peptides by hydrodynamic volume and is often calibrated with known protein standards. Amino acid analysis after acid hydrolysis provides the compositional profile, which can confirm the collagen origin. Mass spectrometry offers detailed sequence information for individual peptides. These methods together help ensure that a product matches its specification and that batch-to-batch variability is controlled.
Collagen peptides are short chains of amino acids produced by hydrolyzing collagen, a structural protein found in skin, bone, and connective tissue. The hydrolysis process breaks the triple-helical collagen molecule into smaller fragments, typically ranging from two to twenty amino acids in length. This reduction in size increases solubility in water and improves absorption compared to intact collagen. The resulting material is a mixture of peptides rather than a single defined compound. Commercial sources include bovine hide, porcine skin, fish scales, and eggshell membrane.
The amino acid profile of collagen peptides is distinctive, with high proportions of glycine, proline, and hydroxyproline. These three residues make up roughly half of the total amino acid content in typical mammalian collagen. Hydroxyproline is formed by post-translational modification of proline and is uncommon in most other proteins. The presence of hydroxyproline serves as a marker for collagen-derived material in analytical testing. Peptide length and distribution depend on the hydrolysis conditions, including temperature, time, and enzyme or acid concentration.
Collagen peptides are typically sold as a powder that dissolves readily in cold or warm liquids. The powder is usually off-white to light yellow and has a mild taste, though some products may have a slight odor. Molecular weight distributions commonly range from about 1,000 to 5,000 daltons, but this varies by manufacturer and intended use. Smaller peptides are generally more soluble, while larger fragments may form viscous solutions. The material is hygroscopic and should be stored in sealed containers away from moisture and heat.
== History == The US Food and Drug Administration (FDA) approved eptinezumab based primarily on evidence from two clinical trials (Trial 1/NCT02559895 and Trial 2/NCT02974153) of 1741 participants with chronic or episodic migraine headaches. Trials were conducted at 212 sites in United States, Georgia, Russia, Ukraine and the European Union. The benefit and side effects of eptinezumab were evaluated in two clinical trials of adults aged 18 through 71 years of age with a history of migraine headaches. The trials had similar designs. Trial 1 enrolled participants with a history of episodic migraine headaches and Trial 2 enrolled participants with chronic migraine headaches. Participants were assigned to receive one of two doses of eptinezumab or placebo injections every three months for a total of twelve months in Trial 1, and for a total of 6 months in Trial 2. Neither the participants nor the health care providers knew which treatment was being given until the trial was completed. The benefit of eptinezumab in comparison to placebo was assessed based on the change in the number of migraine days per month during the first three-month treatment period.
== History == Eucalyptus was founded in 2019 by Tim Doyle, Charlie Gearside, Benny Kleist, and Alexey Mitko. The company launched Pilot, a men's health telehealth service, as its first brand. Subsequent brands included Juniper (weight management), Software (dermatology), and Kin (fertility and reproductive health). In June 2023, Eucalyptus acquired the digital assets of Jenny Craig Australia after the brand entered voluntary administration. The company raised A$8 million in Series A funding in May 2020, $30 million in Series B in July 2021, and $60 million in Series C in January 2022. A 2023 funding round raised an additional A$50 million. The company was valued at $560 million in April 2023. In February 2026, Eucalyptus was acquired by Hims & Hers Health in a transaction valued at up to US$1.15 billion. The transaction was completed in June 2026.
Thorburn Brailsford Robertson (4 March 1884 – 18 January 1930), generally known as Brailsford Robertson, was an Australian academic, physiologist, biochemist, gerontologist, and animal nutritionist. Driven by his view, "Do the best you can with what you have where you are", he was "widely regarded as having possessed a rare capacity both as a teacher and researcher". Robertson's assignment of the rights to his tethelin patent (BR.18, BR.19) to the University of California (UC.6) in September 1917 is universally treated as a landmark precedent event in the subsequent development of what is now known as university technology transfer. His initial research interests were in the physical and biochemical processes underlying nervous activity, cognition, human growth, and senescence. Following the Canadian discovery of insulin, he became deeply involved in both researching the insulin treatment of diabetes mellitus and the Australian production of insulin, which he undertook (in mid-1922) with the direct permission (and precise details of its production) of the Head of the Physiology Department of the University of Toronto, John Macleod, Robertson's former assistant at Toronto, centred on the campus of the University of Adelaide: not only refining and purifying its extraction from bovine pancreases, but also significantly reducing its cost per dose, prior to its full-scale commercial production being transferred to the Commonwealth Serum Laboratories on 1 May 1924.
=== EC 1.5.98 With other, known, physiological acceptors === EC 1.5.98.1: ethylenetetrahydromethanopterin dehydrogenase EC 1.5.98.2: 5,10-methylenetetrahydromethanopterin reductase EC 1.5.98.3: coenzyme F420:methanophenazine dehydrogenase
Sources: en.wikipedia.org
A complicating factor is that a single ion channel may have multiple internal "gates" that respond to changes in Vm in opposite ways, or at different rates. For example, although raising Vm opens most gates in the voltage-sensitive sodium channel, it also closes the channel's "inactivation gate", albeit more slowly. Hence, when Vm is raised suddenly, the sodium channels open initially, but then close due to the slower inactivation. The voltages and currents of the action potential in all of its phases were modeled accurately by Alan Lloyd Hodgkin and Andrew Huxley in 1952, for which they were awarded the Nobel Prize in Physiology or Medicine in 1963. However, their model considers only two types of voltage-sensitive ion channels, and makes several assumptions about them, e.g., that their internal gates open and close independently of one another. In reality, there are many types of ion channels, and they do not always open and close independently.
== Ribose 5-phosphates: histidine == In E. coli, the biosynthesis begins with phosphorylation of 5-phosphoribosyl-pyrophosphate (PRPP), catalyzed by ATP-phosphoribosyl transferase. Phosphoribosyl-ATP converts to phosphoribosyl-AMP (PRAMP). His4 then catalyzes the formation of phosphoribosylformiminoAICAR-phosphate, which is then converted to phosphoribulosylformimino-AICAR-P by the His6 gene product. His7 splits phosphoribulosylformimino-AICAR-P to form D-erythro-imidazole-glycerol-phosphate. After, His3 forms imidazole acetol-phosphate releasing water. His5 then makes L-histidinol-phosphate, which is then hydrolyzed by His2 making histidinol. His4 catalyzes the oxidation of L-histidinol to form L-histidinal, an amino aldehyde. In the last step, L-histidinal is converted to L-histidine.
Here, a stock solution of glutamine is added in increasing increments with a high-accuracy instrument and diluted to the same volume in volumetric flasks. The result is 4 standard solutions with varying known concentrations (along with a blank for instrument calibration). The final concentration in each is calculated using the formula for molar concentration.
Sources: en.wikipedia.org
Collagen peptides are short chains of amino acids made by hydrolyzing native collagen. They are water-soluble and do not form gels like gelatin.
Gelatin is partially hydrolyzed collagen that can form a gel in water. Collagen peptides are further broken down into smaller fragments and remain soluble without gelling.
No. Native collagen is a large triple-helical protein, while collagen peptides are fragmented and lose the triple-helical structure. The two differ in molecular size, solubility, and behavior.
Common methods include size-exclusion chromatography and mass spectrometry. Amino acid analysis provides composition data but not chain length. Results depend on calibration standards and sample preparation.